http://rdf.ncbi.nlm.nih.gov/pubchem/patent/FR-2792637-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_880cc8535f892eca8121f608c316808c
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H17-08
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H17-08
filingDate 1999-04-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4d157f6340ae81680b3f636b76508c28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8519b40f594473dc2fed8b9fc45ab8ab
publicationDate 2000-10-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber FR-2792637-A1
titleOfInvention NOVEL DERIVATIVES OF ERYTHROMYCIN, PROCESS FOR PREPARING THEM AND THEIR APPLICATION AS MEDICAMENTS
abstract The subject of the invention is the compounds of formula (I) (CF DRAWING IN BOPI) in which R represents a radical (CH2) m On (X) YArd in which m represents the number 0 or 1, n represents the number 0 or 1 , X represents a radical (NH) a 'CH2 or SO2 with a representing the number 0 or 1, Y represents a radical (CH2) b - (CH = CH) c - (CH2) d with c = 0 or 1, b + c + d <= 8, Z represents a hydrogen or halogen atom, Ar represents an optionally substituted aryl or heteroaryl radical, W represents a hydrogen atom or an acyl radical, as well as their addition salts with acids. The compounds of formula (1) exhibit antibiotic properties.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1579864-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-03090760-A1
priorityDate 1999-04-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9809978-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/FR-2745290-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/FR-2742757-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID410577672
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449188381
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID480
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449550202
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419527520
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419524677
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457814457
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448078373
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21584172
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426256982
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID88044853
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID962
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457830924
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID220568
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393636
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID480
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID727
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID425258636
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458397158
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23583173
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21705897
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393345
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID297
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458392451
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID12560
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID727
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID1392
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID15192
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419526621
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID1392

Total number of triples: 49.